AMENDMENT NO. 5 TO Securities Purchase AgreementSecurities Purchase Agreement • January 3rd, 2017 • Cipher Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment No. 5 to Securities Purchase AGREEMENT is entered into as of December 30, 2016 (this “Amendment”), among Cipher Pharmaceuticals INC., an Ontario corporation (the “Issuer”), the Guarantors party hereto, Athyrium Opportunities II Acquisition LP, as a Purchaser, the other Purchasers party hereto (collectively, the “Purchasers”) and Athyrium Opportunities II Acquisition LP, as Collateral Agent.
